Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société QIAGEN N.V.
10/22QIAGEN N : Strengthens UK Footprint With Move to New Manchester Facilities
BU
10/20QIAGEN N.V. : to Release Results for Q3 2021 and First Nine Months of 2021
BU
10/19QIAGEN N : Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Region..
BU
10/19QIAGEN N.V. : Release of a capital market information
EQ
10/08QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
10/01QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
09/30QIAGEN N : Receives U.S. Department of Defense Contract to Further Expand Production Capac..
BU
09/22QIAGEN N : Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/..
PU
09/17QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
09/14QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
09/07QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
09/03QIAGEN N : to Enter the DAX – Germany's Leading Stock Market Index
BU
08/30QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
08/26QIAGEN N : announces the commercialization of the PreAnalytiX PAXgene® Saliva Collector fo..
PU
08/23QIAGEN N : Reaches Milestone With Its Kits Used to Process More Than Three Billion Biologi..
BU
08/20QIAGEN N : 2021 IFRS Half Year Report
PU
08/18QIAGEN N.V. : Preliminary announcement of the publication of financial reports according t..
EQ
08/10QIAGEN N : and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detectio..
BU
08/09QIAGEN N : and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreem..
BU
08/06QIAGEN N : receives U.S. FDA emergency use authorization for rapid portable test that can ..
BU
08/02QIAGEN N.V. : Release of a capital market information
EQ
08/02QIAGEN N : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS (Form 6-K)
PU
08/02QIAGEN N : Chief Financial Officer (Form 6-K)
PU
07/30QIAGEN N : Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiag..
PR
07/30QIAGEN N : QIAGEN reports full results for Q2 and H1 2021
PU
07/29QIAGEN : Q2 Earnings Snapshot
AQ
07/29QIAGEN N : Reports Full Results for Q2 and H1 2021
BU
07/27QIAGEN N.V. : Release of a capital market information
EQ
07/20QIAGEN N : Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/..
PU
07/13QIAGEN N : QIAGEN announces preliminary Q2 2021 results and updates 2021 outlook/QIAGEN to..
PU
07/13QIAGEN N : QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-ye..
PU
07/12QIAGEN N.V. : Conference Call on July 13 to Discuss Preliminary Q2 2021 Results
BU
07/12QIAGEN N : announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021..
BU
07/08QIAGEN N : NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Test..
BU
07/07QIAGEN N : launches the Workflow Configurator to help life science researchers simplify an..
BU
07/02QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
07/01QIAGEN N : Forms Strategic Alliance With Sysmex Corporation for Global Cancer Companion Di..
BU
06/29VEROGEN : Partners with QIAGEN to Deliver Innovative Solutions for Human Identification La..
BU
06/29QIAGEN N : Partners with Verogen to Offer Broadest Portfolio for Human Identification, Inc..
BU
06/25QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
06/21QIAGEN N : Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Ed..
BU
06/11QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
06/08QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
05/28QIAGEN N : Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G1..
BU
05/27QIAGEN N : Investment breakthrough for BrainRepair UG start-up - Stem cell treatment for n..
AQ
05/27BRAINREPAIR UG : Investment breakthrough for BrainRepair UG start-up – Stem cell tre..
AQ
05/27QIAGEN N : Investment breakthrough for BrainRepair UG start-up – Stem cell treatment..
AQ
05/27QIAGEN N : 2020 GRI Content Index and Sustainability Accounting Standards Board (SASB) Ind..
PU
05/25QIAGEN N : Partners With Mirati Therapeutics Inc. to Develop KRASG12C Companion Diagnostic..
BU
05/19QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
05/17QIAGEN N : Announces Creation of Scientific Advisory Board and Agenda for Annual General M..
BU
05/14QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
05/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
05/12QIAGEN N : 2020 Annual Financial Report
PU
05/12QIAGEN N : Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital ..
BU
05/06QIAGEN N : Clinical Laboratory Tests Market To Demonstrate Massive Growth By 2027 Owing To..
AQ
05/05QIAGEN N : And subsidiaries u.s. gaap quarterly report for the period ended march 31, 2021
PU
05/05QIAGEN N : Chief Financial Officer
PU
05/05QIAGEN N.V. : Release according to Article 50 of the WpHG [the German Securities Trading A..
EQ
05/04QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
05/03QIAGEN N : Insights Magazine 2021
PU
05/03QIAGEN : Q1 Earnings Snapshot
AQ
05/03QIAGEN N : Exceeds Outlook in First Quarter 2021 Results, Reaffirms Sales Growth and Profi..
BU
04/29QIAGEN N : 2020 IFRS Annual Report
PU
04/23QIAGEN N.V. : Preliminary announcement of the publication of financial reports according t..
EQ
04/21QIAGEN N : in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDete..
BU
04/20QIAGEN N : Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold I..
BU
04/20QIAGEN N.V. : to Report First Quarter 2021 Results
BU
04/16QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
04/06QIAGEN N : Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Thr..
BU
03/29QIAGEN N : Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding C..
BU
03/26QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
03/24QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
03/19QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
03/12QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
1  2  3  4  5  6  7  8Next
Upcoming event on QIAGEN N.V.
11/03/21
Upcoming sector events